RAD51B / DNA repair protein RAD51 homolog 2 · Western blot design guide

Design a Western Blot for RAD51B

Source-linked RAD51B Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAD51B WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RAD51B: expected band ~42.2 kDa, hero antibody A20019, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable RAD51B Western blot protocol sheet — expected band ~42.2 kDa, antibody A20019, controls and PMC citations. Open the full RAD51B WB guide →

RAD51B Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~42.2 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Adrenal gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated
Caveat Phosphorylation-state controls
Gene-set association MSigDB C7 membership
Isoform 5 isoform(s)
Section 1

Source-Linked RAD51B Western Blot Protocol Options

The A20019 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatelysates from COS7 cells, (catalog A20019)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blockingthe synthesized peptide (catalog A20019)
Primary antibodyA20019; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected RAD51B Western Blot Band Size?

RAD51B is predicted at 42.2 kDa; five isoforms could affect band patterns, but distinct migration has not been demonstrated.

What am I looking at on my blot?
Band near 42.2 kDaConsistent with the predicted RAD51B size; confirm identity with controls
Two bands at different positionsCould reflect splice isoforms; their migration is not established
Several bands at different positionsCould reflect the five annotated isoforms; confirm each band’s identity
Stronger band in a nuclear fractionConsistent with RAD51B’s nuclear location
💡Expected RAD51B appearanceRAD51B has a predicted mass of 42.2 kDa; no empirical band size or isoform-specific migration is supplied, so confirm any candidate band with ordinary identity controls.
How each factor affects band size
UniProt predicted massPlaces the predicted protein near 42.2 kDa
Splice isoform 1Its individual mass and migration are not supplied
Splice isoform 2May differ in size; its migration is not established
Splice isoform 3May differ in size; its migration is not established
Splice isoform 4May differ in size; its migration is not established
Splice isoform 5May differ in size; its migration is not established
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNuclear RAD51B may be dilute in whole-cell lysateCheck a nuclear fraction and a positive control
Multiple bandsRAD51B has five annotated splice isoforms, but their migration is unknownUse knockdown and isoform-aware controls to identify bands
Band higher than expectedNo listed modification establishes a higher apparent massCheck band identity with knockdown and an independent antibody
Band lower than expectedAn isoform is possible, but no isoform-specific mass is suppliedCheck band identity and antibody epitope coverage
Weak or no signalNuclear RAD51B may be underrepresented in the sampleVerify loading and enrich the nuclear fraction

Sample controls for RAD51B Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for RAD51B in Western blot, you can use adrenal gland lysate, which has high HPA expression.
Positive control: Adrenal gland (IHC candidate; verify WB)
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: No supplied tissue is HPA Not detected, so use siRNA knockdown or a KO line for a negative control.

HPA tissue expression evidence for RAD51B

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adrenal gland glandular cells High Protein (IHC) HPA →
Appendix glandular cells High Protein (IHC) HPA →
Bone marrow hematopoietic cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Bronchus respiratory epithelial cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Medium Protein (IHC) HPA →
Heart muscle cardiomyocytes Medium Protein (IHC) HPA →
Prostate glandular cells Medium Protein (IHC) HPA →
Vagina squamous epithelial cells Medium Protein (IHC) HPA →
Adrenal gland glandular cells High Protein (IHC) HPA →
Section 3

Advanced RAD51B Western Blot Tips

Deeper troubleshooting and optimisation questions for RAD51B, answered from its protein features.

Where should the canonical RAD51B band appear?
Band shift · The canonical 384-residue sequence has a predicted mass of 42.2 kDa. No observed band position is supplied, so use 42.2 kDa as a reference, not a guaranteed migration position.
Could RAD51B isoforms produce different bands?
Isoforms · Five isoforms are listed. Isoform 5 lacks residues 1–119; isoforms 2, 3, 4 and 5 have changes near the C-terminus. These sequence differences could affect apparent bands, but the features do not establish which isoforms are expressed or visible.

Check whether the epitope overlaps residues 1–119, absent from isoform 5, or the altered C-terminal region around residues 346–384. An antibody against either region may recognize the isoforms differently. Coordinates here follow the supplied UniProt canonical sequence.
Can phosphorylation explain a shifted RAD51B band?
PTM · UniProt labels RAD51B a phosphoprotein but lists no modified residue or phosphorylation site in the supplied features. That keyword alone cannot establish a visible shift or explain a measured mass difference.
Does this guide establish induction of RAD51B?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for RAD51B?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A20019 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should RAD51B bands be quantified across samples?
Quantitation · Keep the antibody epitope in mind when comparing bands: the five listed isoforms differ at the N-terminus or C-terminus. Quantify the same defined band or band set across samples, and report which bands were included.
How should unexpected RAD51B bands be interpreted?
Interpretation · Compare them with the 42.2 kDa canonical prediction and the listed isoform sequence changes. A band at another position is not, by itself, evidence of an isoform or modification; the supplied features include no empirical band position or mapped modified residue.
Boster reagents

RAD51B Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of lysates from COS7 cells, using RAD51L1 Antibody. The lane on the right is blocked with the synthesized peptide.
Anti-RAD51L1 RAD51B Antibody
Cat # A20019
Real WB data Western blot analysis of RAD51L1/RAD51B using anti-RAD51L1/RAD51B antibody (A02658-2). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Jurkat whole cell lysates, Lane 2: human Hacat whole cell lysates, Lane 3: human U20S whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-RAD51L1/RAD51B antigen affinity purified polyclonal antibody (A02658-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for RAD51L1/RAD51B at approximately 42 kDa. The expected band size for RAD51L1/RAD51B is at 42 kDa.
Anti-RAD51L1/RAD51B Antibody Picoband®
Cat # A02658-2

Two the supplier anti-RAD51B antibodies have WB images: A20019 in COS7 lysate with a peptide-blocked lane, and A02658-2 in three human cell lysates with a reported ~42 kDa band. These examples do not establish performance across all listed reactive species or sample types.

Which to pick: For human cell lysates, A02658-2 has documented WB results in Jurkat, HaCaT and U2OS samples. A20019 lists human, monkey and mouse reactivity, with a COS7 WB image and peptide-blocked lane; the supplied evidence does not show WB results for every listed species.

Source: BosterBio RAD51B gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.